FDA restricts use of Johnson & Johnson COVID-19 vaccine

The FDA has restricted the use of Johnson & Johnson’s COVID-19 vaccine based on an updated analysis of the risk for a rare but potentially deadly blood-clotting syndrome.
The vaccine will be available only to people aged 18 years or older “for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate” or “who elect to receive the [vaccine] because they would otherwise not receive a COVID-19 vaccine,” the FDA said.
The FDA said it based the restrictions on an updated analysis of the risk for thrombosis with thrombocytopenia

The FDA has restricted the use of Johnson & Johnson’s COVID-19 vaccine based on an updated analysis of the risk for a rare but potentially deadly blood-clotting syndrome.
The vaccine will be available only to people aged 18 years or older “for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate” or “who elect to receive the [vaccine] because they would otherwise not receive a COVID-19 vaccine,” the FDA said.
The FDA said it based the restrictions on an updated analysis of the risk for thrombosis with thrombocytopenia